Largest biotech and pharma deals – 2018 recap & 2019 outlook
The year 2019 started out strong with the announcement of Bristol Myers Squibb acquisition of Celgene for about $74 billion. However, before delving further into the possible deal trends that could be expected in 2019, let us look back and honor some of the major acquisition and partnership deals that companies landed in 2018. Read here!
January 23, 2019
Our success depends on how well our clients perform. We are here to equip them with the right tools and empower them with the right insight, so they confidently can strike deals, partnerships and attract investments.
We understand the business issues facing smaller biotech companies and share a passion with our clients to drive the future of medicine.
We support leaders with actionable recommendations and insights with a fervor and razor-sharp focus. Our approach is doing so by creating tailored solutions to challenging business issues and crafting strategies to achieve business goals and brand visibility. Whether it is business development, asset valuation or communication, we are a reliable partner that always walk that extra mile.